Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Current Taxes: 2024-2025

  • Kura Oncology's Current Taxes was N/A to $2.3 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.3 million, marking a year-over-year change of. This contributed to the annual value of $2.1 million for FY2024, which is N/A change from last year.
  • As of Q1 2025, Kura Oncology's Current Taxes stood at $2.3 million, which was up 10.97% from $2.1 million recorded in Q4 2024.
  • In the past 5 years, Kura Oncology's Current Taxes ranged from a high of $2.3 million in Q1 2025 and a low of $2.1 million during Q4 2024.
  • Its 2-year average for Current Taxes is $2.2 million, with a median of $2.2 million in 2024.